Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting

Table 1 Demographics of 100 patients included in the retrospective review of pharmacogenomics result

Patient characteristics
Sex	(%)
Male	44
Female	56
Age (yr)	(%)
18-29	23
30-39	12
40-49	29
50-59	17
60-69	14
> 70	5
Referring specialists	(%)
Psychiatrists	39
Immunologists	15
General practitioners	10
Neurologists	9
Transplant physicians	8
Clinical pharmacologists	5
Others1	14
Indications for referral	(%)
To guide pharmacotherapy	62
Previous drug reactions	51
Polypharmacy2	5
Pre-emptive testing	5
Did not specify	5

¹Cardiologist, endocrinologist, gastroenterologist, haematologist, nephrologist, psychologist, obstetrician, rheumatologist and thoracic physician referred.

²Patient taking ≥ 5 prescription medications. Referring clinicians could list more than one indication for pharmacogenomics testing.